Cell therapy is the therapeutic application of cells despite cell kind or clinical indication – a platform technology. Regenerative drugs is an approach to treating patients and so definitely not a platform technology. It’s nearest to a hospital specialty, for example, medicine, medical specialty or palliative drugs, in alternative words platform technology independent. Its goals are ultimately to cure and so a paradigm shift away from typical symptom management and pain management. While it’s true that some cell therapies are regenerative, the bulk are not. Even as regenerative drugs is much larger than regenerative cell therapies alone, cell therapies collectively represent a market opportunity several orders of magnitude bigger than regenerative drugs. Equating one with the other is therefore not advantageous however instead will each a major disservice.
Market Insights
The global Cell Therapy Processing market is expected to be around US$ 21 Billion by 2028, at a CAGR of 16.2% in the given forecast period.
The global Cell Therapy Processing market is segregated on the basis of Process as Cell Processing, Cell Preservation, Distribution, and Handling, and Process Monitoring and Quality Control. Based on Product Type the global Cell Therapy Processing market is segmented in Equipment, 1 Cell Processing Equipment, 2 Single-Use Equipment, 3 Other Equipment, Systems & Software, and Consumables. Based on End User the global Cell Therapy Processing market is segmented in Life Science Research Companies and Research Institutes.
Based on Cell Type, the global Cell Therapy Processing market is segmented in Human Cells, 1 Stem Cells, 2 Differentiated Cells, and Animal Cells.
The global Cell Therapy Processing market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Cell Therapy Processing market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Stemcell Technologies, Miltenyi Biotec GmbH, Beckman Coulter, Inc, Becton, Dickinson and Company, Ge Healthcare, Sartorius, Merck KGaA, Lonza Group, Thermo Fisher Scientific, Inc., Terumo Bct, Inc, and others are among the major players in the global Cell Therapy Processing market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Cell Therapy Processing Market has been segmented as below:
Cell Therapy Processing Market, By Process
Cell Therapy Processing Market, By Product Type
Cell Therapy Processing Market, By End User
Cell Therapy Processing Market, By Cell Type
Cell Therapy Processing Market, By Region
Cell Therapy Processing Market, By Company
The report covers:
Report Scope:
The global Cell Therapy Processing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Cell Therapy Processing market share. Major industry players with significant revenue share include Stemcell Technologies, Miltenyi Biotec GmbH , Beckman Coulter, Inc, Becton, Dickinson and Company, Ge Healthcare, Sartorius , Merck KGaA, , Lonza Group , Thermo Fisher Scientific, Inc., Terumo Bct, Inc, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Cell Therapy Processing Market, By Process
5.1 Introduction
5.2 Cell Processing
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cell Preservation, Distribution, and Handling
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Process Monitoring and Quality Control
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Cell Therapy Processing Market, By Product Type
6.1 Introduction
6.2 Equipment
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 1 Cell Processing Equipment
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 2 Single-Use Equipment
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 3 Other Equipment
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Systems & Software
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Consumables
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Cell Therapy Processing Market, By End User
7.1 Introduction
7.2 Life Science Research Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Research Institutes
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Cell Therapy Processing Market, By Cell Type
8.1 Introduction
8.2 Human Cells
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 1 Stem Cells
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 2 Differentiated Cells
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Animal Cells
8.5.1 Market Overview
8.5.2 Market Size and Forecast
9. Cell Therapy Processing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Cell Therapy Processing, By Process
9.2.2 North America Cell Therapy Processing, By Product Type
9.2.3 North America Cell Therapy Processing, By End User
9.2.4 North America Cell Therapy Processing, By Cell Type
9.3 Europe
9.3.1 Europe Cell Therapy Processing, By Process
9.3.2 Europe Cell Therapy Processing, By Product Type
9.3.3 Europe Cell Therapy Processing, By End User
9.3.4 Europe Cell Therapy Processing, By Cell Type
9.4 Asia-Pacific
9.4.1 Asia-Pacific Cell Therapy Processing, By Process
9.4.2 Asia-Pacific Cell Therapy Processing, By Product Type
9.4.3 Asia-Pacific Cell Therapy Processing, By End User
9.4.4 Asia-Pacific Cell Therapy Processing, By Cell Type
9.5 Rest of the World
9.5.1 Rest of the World Cell Therapy Processing, By Process
9.5.2 Rest of the World Cell Therapy Processing, By Product Type
9.5.3 Rest of the World Cell Therapy Processing, By End User
9.5.4 Rest of the World Cell Therapy Processing, By Cell Type
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Stemcell Technologies
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Miltenyi Biotec GmbH
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Beckman Coulter, Inc
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Becton, Dickinson and Company
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Ge Healthcare
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Sartorius
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Merck KGaA
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Lonza Group
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Terumo Bct, Inc
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Cell Therapy Processing Market has been segmented as below:
Cell Therapy Processing Market, By Process
Cell Therapy Processing Market, By Product Type
Cell Therapy Processing Market, By End User
Cell Therapy Processing Market, By Cell Type
Cell Therapy Processing Market, By Region
Cell Therapy Processing Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
